Pharmaceutical Research and Manufacturers of America(PhRMA) pays for pro-health reform TV ad: spent $20 million lobbying congress

Friday, July 17, 2009

Pharmaceutical Research and Manufacturers of America(PhRMA) pays for pro-health reform TV ad: spent $20 million lobbying congress --soulful sepulcher blog

AstraZeneca earned over 4$billion dollars in 2008 from Seroquel, the anti psychotic in lawsuits for alleged diabetes injuries, and the latest add-on for "depression".

Placebo outperformed Seroquel in a teen bipolar study and has a black box warning for diabetes as a side effect, also known for adding unwanted weight gain.

The internal documents show that AstraZeneca knew of the risks before the drug went to market.

Health reform and PhRMA (Pharmaceutical Research and Manufacturers of America) David Brennan Elected PhRMA Board ChairmanWashington, D.C. (April 3, 2009)

— David Brennan, Chief Executive Officer, AstraZeneca, was elected board chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA) today at the trade association’s annual meeting.

Also elected were Pfizer Chairman and Chief Executive Officer Jeffrey B. Kindler as chairman-elect of the PhRMA Board of Directors and David Y. Norton, Company Group Chairman, Worldwide Commercial and Operations for the Johnson & Johnson Pharmaceuticals Group, as board treasurer.

“The PhRMA member companies accomplished much this past year. We strengthened our marketing code, tightened our DTC advertising principles and voiced strong support of transparency of company interactions with physicians,” said Clark.

“I am also proud of PhRMA’s commitment in support of health care reform, including expanding coverage to all Americans.

In this time of economic turmoil, the last thing American families should have to worry about is their health care coverage.

No one should have to go without the medicines and vaccines they need.

"Mr. Brennan was named chief executive officer of AstraZeneca in January 2006. From 2001 through 2005 he was president and chief executive officer of AstraZeneca LP, the company’s North America subsidiary. In 2005, Mr. Brennan was appointed executive board director of AstraZeneca, with responsibility for all North American operations."

--

Friday, June 26, 2009,$1.2 million a day: Pharma lobbying Congress, using ex-Congressmen and Senators-soulful sepulcher blog

Open Secrets blog: Will $1.2 Million a Day Convince Congress to Buy Big Pharma's Rx for Change?

"Within this industry, the trade group Pharmaceutical Research and Manufacturers of America (PhRMA) leads the way on lobbying activities, spending more than $20.2 million last year, or $10,750 an hour that Congress was in session."PhRMA paid for this television ad, supporting health reform.

--

Feel like a pawn on a political platform masked as health reform? or a marketing target for PhRMA? you're right! it's all about profit$$, not you! --July 2009

---

Geoff Birkett and David Brennan have many answers that I WANT.